166 related articles for article (PubMed ID: 27270858)
1. Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.
Wang TY; Lee SY; Chen SL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Sci Rep; 2016 Jun; 6():27431. PubMed ID: 27270858
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
[TBL] [Abstract][Full Text] [Related]
3. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
[TBL] [Abstract][Full Text] [Related]
4. Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.
Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Alcohol Clin Exp Res; 2018 Jun; 42(6):1044-1050. PubMed ID: 29656414
[TBL] [Abstract][Full Text] [Related]
5. Genotype variant associated with add-on memantine in bipolar II disorder.
Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
Int J Neuropsychopharmacol; 2014 Feb; 17(2):189-97. PubMed ID: 24103632
[TBL] [Abstract][Full Text] [Related]
6. Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
PLoS One; 2013; 8(6):e66847. PubMed ID: 23826157
[TBL] [Abstract][Full Text] [Related]
7. The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders.
Wang TY; Lee SY; Chen SL; Chung YL; Li CL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Hsieh TH; Chiu YC; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 26865313
[TBL] [Abstract][Full Text] [Related]
8. Add-on memantine may improve cognitive functions and attenuate inflammation in middle- to old-aged bipolar II disorder patients.
Lu RB; Wang TY; Lee SY; Chang YH; Chen SL; Tsai TY; Chen PS; Huang SY; Tzeng NS; Lee IH; Chen KC; Yang YK; Hong JS
J Affect Disord; 2021 Jan; 279():229-238. PubMed ID: 33069121
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Acta Psychiatr Scand; 2015 Feb; 131(2):120-8. PubMed ID: 25131388
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
Kauer-Sant'Anna M; Kapczinski F; Andreazza AC; Bond DJ; Lam RW; Young LT; Yatham LN
Int J Neuropsychopharmacol; 2009 May; 12(4):447-58. PubMed ID: 18771602
[TBL] [Abstract][Full Text] [Related]
12. The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder.
Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
J Affect Disord; 2012 May; 138(3):295-300. PubMed ID: 22326841
[TBL] [Abstract][Full Text] [Related]
13. The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism.
Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Yang YH; Lu RB; Chen CS
Sci Rep; 2016 Dec; 6():37950. PubMed ID: 27905499
[TBL] [Abstract][Full Text] [Related]
14. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
[TBL] [Abstract][Full Text] [Related]
15. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
16. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
[TBL] [Abstract][Full Text] [Related]
17. Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
Berk M; Ng F; Wang WV; Tohen M; Lubman DI; Vieta E; Dodd S
J Affect Disord; 2008 Sep; 110(1-2):126-34. PubMed ID: 18280579
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
19. Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers.
Huang TL; Hung YY; Lee CT; Chen RF
Neuropsychobiology; 2012; 65(2):65-9. PubMed ID: 22222435
[TBL] [Abstract][Full Text] [Related]
20. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
